These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3436 related articles for article (PubMed ID: 7332319)

  • 21. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative pathway of complement activation by stimulated T lymphocytes. II. Elevation of cytotoxic potential against complement receptor-carrying cell lines.
    Ramos OF; Sármay G; Eggertsen G; Nilsson B; Klein E; Gergely J
    Eur J Immunol; 1987 Jul; 17(7):975-9. PubMed ID: 3111863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.
    Taniguchi-Sidle A; Isenman DE
    J Immunol; 1994 Dec; 153(11):5285-302. PubMed ID: 7963581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between C3 and IL-2; inhibition of C3b binding to CR1 by IL-2.
    Bartók I; Erdei A; Mouzaki A; Osawa H; Szölösi J; Eigentler A; Diamantstein T; Dierich MP; Gergely J
    Immunol Lett; 1989 May; 21(2):131-7. PubMed ID: 2527811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
    Garred P; Mollnes TE; Lea T; Fischer E
    Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of membrane phospholipids on activation of the alternative complement pathway.
    Mold C
    J Immunol; 1989 Sep; 143(5):1663-8. PubMed ID: 2527270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective binding of the third component of complement (C3) to Streptococcus pneumoniae in multiple myeloma.
    Cheson BD; Walker HS; Heath ME; Gobel RJ; Janatova J
    Blood; 1984 Apr; 63(4):949-57. PubMed ID: 6231069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C3 cleaved by membrane proteases binds to C3b acceptors expressed on concanavalin A-stimulated human lymphocytes and enhances antibody-dependent cellular cytotoxicity.
    Erdei A; Benczur M; Fábry Z; Dierich MP; Gergely J
    Scand J Immunol; 1984 Aug; 20(2):125-31. PubMed ID: 6236547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C3b acceptors on macrophages: inhibition of Fc gamma-receptor-mediated phagocytosis by acceptor-bound C3b.
    Fábry Z; Erdei A; Gergely J
    Immunol Lett; 1983 Jun; 6(6):287-91. PubMed ID: 6226600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cleavage of the complement system C3 component by HIV-1 proteinase.
    Kisselev AF; Mentele R; von der Helm K
    Biol Chem; 1997 May; 378(5):439-42. PubMed ID: 9191031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Sep; 154(3):856-67. PubMed ID: 6912277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum.
    Ramos OF; Sármay G; Klein E; Yefenof E; Gergely J
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5470-4. PubMed ID: 3895232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of a biologically active macrophage receptor for the third component of complement.
    Schneider RJ; Kulczycki A; Law SK; Atkinson JP
    Nature; 1981 Apr; 290(5809):789-92. PubMed ID: 7219564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of rabbit C3: studies of the generation of cleavage products in vitro and of their metabolism in vivo.
    Peake PW; Charlesworth JA; Pussell BA
    Complement Inflamm; 1991; 8(5-6):261-70. PubMed ID: 1802545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    Lambris JD; Ross GD
    J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of radiographic contrast media on complement components C3 and C4: generation of C3b-like C3 and C4b-like C4.
    von Zabern I; Przyklenk H; Vogt W; Sachsenheimer W
    Int J Immunopharmacol; 1983; 5(6):503-13. PubMed ID: 6607225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 172.